Rocket Lab files financial statements related to pending Iridium merger
Rocket Lab files financial statements related to pending Iridium merger
Rocket Lab Corp (NASDAQ:RKLB) on Thursday filed financial and pro forma statements with the Securities and Exchange Commission in connection with its pending acquisition of Iridium Communications Inc. The filing, based on a press release statement, provides updated financial information for both companies as required for the merger process.The space technology company, valued at $48.6 billion, has seen its stock surge nearly 89% over the past year. Yet according to InvestingPro analysis, the stock currently appears overvalued relative to its Fair Value, placing it among companies on the most overvalued list.
According to the SEC filing, Rocket Lab previously entered into an Agreement and Plan of Merger with Iridium Communications, Ion Merger Sub I, Inc., and Ion Merger Sub II, LLC on June 28, 2026. Under the terms, Ion Merger Sub I will merge with and into Iridium, making Iridium an indirect wholly owned subsidiary of Rocket Lab. The surviving corporation from this first merger will then merge with Ion Merger Sub II, which will continue as the surviving entity.Rocket Lab enters this acquisition from a position of financial strength, holding more cash than debt on its balance sheet with a current ratio of 5.48. The company posted 53% revenue growth in the last twelve months, though it remains unprofitable. InvestingPro offers 11 additional tips and a comprehensive Pro Research Report on RKLB, part of its coverage of over 1,400 US equities.
The business combination has not yet closed, and financial statements are being provided in anticipation of the transaction. The filing includes audited consolidated financial statements of Iridium as of December 31, 2025 and 2024, as well as unaudited condensed consolidated financial statements as of June 30, 2026 and for the three and six months ended June 30, 2026 and 2025. These materials are incorporated by reference from Iridium’s previously filed annual and quarterly reports.
Rocket Lab also provided unaudited pro forma condensed combined financial statements reflecting the proposed transaction. These pro forma statements include a balance sheet as of June 30, 2026, and statements of operations and comprehensive income (loss) for the six months ended June 30, 2026 and for the year ended December 31, 2025.
The merger remains subject to the satisfaction or waiver of closing conditions, including shareholder and regulatory approvals. Rocket Lab’s filing states that the transaction is still pending, and no securities may be sold until the registration statement becomes effective.
This information is based on a statement included in Rocket Lab’s Form 8-K filed with the SEC.
In other recent news, Rocket Lab USA reported a second-quarter revenue increase of 62% year-over-year, surpassing consensus estimates by 1%. The company has also guided third-quarter revenue to be 8% above consensus. Cantor Fitzgerald raised its price target for Rocket Lab to $122.00, citing the company’s record second-quarter fiscal 2026 revenue of approximately $234.1 million. The Neutron rocket program remains on track for its first launch later this year, according to management.
Needham reiterated a Buy rating with a $120.00 price target, emphasizing strong revenue growth. KeyBanc maintained its Overweight rating with a $135.00 price target, noting accelerating momentum in Space Systems. Citizens reiterated a Market Outperform rating, highlighting improved confidence in the Neutron program’s execution and long-term potential. Stifel also reiterated a Buy rating, pointing out the company’s strong backlog growth, which includes 26 new Electron/HASTE missions and a total backlog of over 90 missions.